{"id":"https://openalex.org/W7119125669","doi":"https://doi.org/10.1158/2326-6066.c.8235387","title":"Data from Circulating Neoantigen- and Viral Oncoprotein\u2013Specific CD8+ T Cells Share a Transcriptional Signature","display_name":"Data from Circulating Neoantigen- and Viral Oncoprotein\u2013Specific CD8+ T Cells Share a Transcriptional Signature","publication_year":2026,"publication_date":"2026-01-08","ids":{"openalex":"https://openalex.org/W7119125669","doi":"https://doi.org/10.1158/2326-6066.c.8235387"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.c.8235387","doi":"https://doi.org/10.1158/2326-6066.c.8235387","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.8235387","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.c.8235387","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007675450","display_name":"Saumya Jani","orcid":"https://orcid.org/0000-0003-1212-1961","observed_orcids":["https://orcid.org/0000-0003-1212-1961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saumya Jani","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1212-1961","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077692699","display_name":"Tomas Bencomo","orcid":"https://orcid.org/0000-0001-6048-8843","observed_orcids":["https://orcid.org/0000-0001-6048-8843"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomas Bencomo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6048-8843","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025562038","display_name":"Carolyn Shasha","orcid":"https://orcid.org/0000-0002-3021-9383","observed_orcids":["https://orcid.org/0000-0002-3021-9383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carolyn Shasha","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3021-9383","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039864776","display_name":"Thomas H. Pulliam","orcid":"https://orcid.org/0000-0003-3511-6348","observed_orcids":["https://orcid.org/0000-0003-3511-6348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Pulliam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3511-6348","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092513108","display_name":"Ana Jojic","orcid":"https://orcid.org/0009-0004-3117-3585","observed_orcids":["https://orcid.org/0009-0004-3117-3585"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana Jojic","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-3117-3585","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015132177","display_name":"Candice D. Church","orcid":"https://orcid.org/0000-0003-1582-8292","observed_orcids":["https://orcid.org/0000-0003-1582-8292"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Candice D. Church","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1582-8292","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023949296","display_name":"Ted Alan Gooley","orcid":"https://orcid.org/0000-0002-8182-3652","observed_orcids":["https://orcid.org/0000-0002-8182-3652"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ted A. Gooley","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8182-3652","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014605629","display_name":"David M. Koelle","orcid":"https://orcid.org/0000-0003-1255-9023","observed_orcids":["https://orcid.org/0000-0003-1255-9023"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Koelle","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1255-9023","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060666271","display_name":"Evan William Newell","orcid":"https://orcid.org/0000-0002-2889-243X","observed_orcids":["https://orcid.org/0000-0002-2889-243X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evan W. Newell","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2889-243X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082643048","display_name":"Paul Nghiem","orcid":"https://orcid.org/0000-0003-2784-963X","observed_orcids":["https://orcid.org/0000-0003-2784-963X","https://orcid.org/0000-0003-2801-7149"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Nghiem","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2784-963X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8564000129699707,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8564000129699707,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.08529999852180481,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.04639999940991402,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9369999766349792},{"id":"https://openalex.org/keywords/tumor-specific-t-cells","display_name":"tumor-specific T cells","score":0.8659999966621399},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.8019999861717224},{"id":"https://openalex.org/keywords/viral-oncoproteins","display_name":"viral oncoproteins","score":0.9169999957084656},{"id":"https://openalex.org/keywords/merkel-cell-carcinoma","display_name":"Merkel cell carcinoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/merkel-cell-polyomavirus","display_name":"Merkel cell polyomavirus","score":0.9679999947547913},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.7630000114440918},{"id":"https://openalex.org/keywords/anti-pd-1-therapy-response","display_name":"anti-PD-1 therapy response","score":0.7120000123977661},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.3370000123977661}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6115999817848206},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.482699990272522},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.47609999775886536},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.44749999046325684},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4180999994277954},{"id":"https://openalex.org/C3017910909","wikidata":"https://www.wikidata.org/wiki/Q618363","display_name":"Peripheral blood","level":2,"score":0.39329999685287476},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.3919000029563904},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.35600000619888306},{"id":"https://openalex.org/C139563560","wikidata":"https://www.wikidata.org/wiki/Q224930","display_name":"Natural killer T cell","level":4,"score":0.3513999879360199},{"id":"https://openalex.org/C2780291066","wikidata":"https://www.wikidata.org/wiki/Q1570264","display_name":"Merkel cell","level":4,"score":0.3499999940395355},{"id":"https://openalex.org/C67662055","wikidata":"https://www.wikidata.org/wiki/Q1047791","display_name":"Antigen-presenting cell","level":4,"score":0.34929999709129333},{"id":"https://openalex.org/C2779696439","wikidata":"https://www.wikidata.org/wiki/Q7512811","display_name":"Signature (topology)","level":2,"score":0.3330000042915344},{"id":"https://openalex.org/C2992881475","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T lymphocyte","level":3,"score":0.3296000063419342},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3257000148296356},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.32420000433921814},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3237999975681305},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.31630000472068787},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.30730000138282776},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.303600013256073},{"id":"https://openalex.org/C189014844","wikidata":"https://www.wikidata.org/wiki/Q189118","display_name":"Cell type","level":3,"score":0.28679999709129333},{"id":"https://openalex.org/C120642132","wikidata":"https://www.wikidata.org/wiki/Q14907110","display_name":"ZAP70","level":5,"score":0.2782000005245209},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.2775000035762787},{"id":"https://openalex.org/C2779979121","wikidata":"https://www.wikidata.org/wiki/Q211709","display_name":"Blood cell","level":2,"score":0.26980000734329224},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2542000114917755}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.c.8235387","doi":"https://doi.org/10.1158/2326-6066.c.8235387","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.8235387","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.c.8235387","doi":"https://doi.org/10.1158/2326-6066.c.8235387","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.8235387","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415477761","https://openalex.org/W4388085386","https://openalex.org/W4389190241","https://openalex.org/W4391639257","https://openalex.org/W7118723738","https://openalex.org/W4388070507","https://openalex.org/W7118652742","https://openalex.org/W4295138736","https://openalex.org/W7118509793","https://openalex.org/W4389241392"],"abstract_inverted_index":{"Abstract":[0],"Tumor-specific":[1,69],"CD8+":[2,34,47,70,78,95,121,132,154,185],"T":[3,35,48,71,79,83,96,122,133,155,167,186,201],"cells":[4,36,49,72,80,84,97,123,134,156,168,187,202],"in":[5,85,213],"blood":[6,52,99],"seem":[7],"to":[8,16,26,126,162,210],"be":[9,211],"important":[10],"for":[11],"and":[12,130,138,157,174],"predictive":[13],"of":[14,32,53,67,107,118,172,177],"response":[15],"anti\u2013PD-1":[17],"therapies.":[18],"However,":[19],"as":[20,111,113],"most":[21],"tumor":[22,193],"antigens":[23],"are":[24,207],"unique":[25],"a":[27,63,145,170,175],"given":[28],"patient,":[29],"the":[30,51,116],"identification":[31],"tumor-specific":[33,94,120],"is":[37],"not":[38],"routinely":[39],"feasible.":[40],"In":[41,104],"this":[42],"study,":[43],"we":[44],"characterized":[45],"polyomavirus-specific":[46],"from":[50,81,98,102,204],"17":[54],"patients":[55],"with":[56,135,169],"virus-driven":[57,205],"Merkel":[58,108,164],"cell":[59,109,165],"carcinoma.":[60],"We":[61,88,142],"identified":[62],"98-gene":[64],"signature":[65,117,149],"[Signature":[66],"Peripheral":[68],"(SPoTT)]":[73],"that":[74,182],"discriminated":[75],"circulating":[76,183],"tumor\u2013specific":[77,184],"other":[82],"immunotherapy-na\u00efve":[86],"patients.":[87],"observed":[89],"profound":[90],"transcriptomic":[91],"differences":[92],"among":[93],"versus":[100],"those":[101],"tumor.":[103],"validation":[105],"cohorts":[106],"carcinoma,":[110],"well":[112],"neoantigen-driven":[114],"cancers,":[115],"peripheral":[119],"was":[124,160],"able":[125,161],"identify":[127],"viral":[128],"oncoprotein-":[129],"neoantigen-specific":[131,153],"both":[136],"sensitivity":[137,171],"specificity":[139,176],"above":[140],"75%.":[141],"also":[143,208],"tested":[144],"previously":[146],"described":[147],"151-gene":[148],"(NeoTCRPBL)":[150],"trained":[151],"on":[152],"found":[158],"it":[159],"recognize":[163],"polyomavirus\u2013specific":[166],"66%":[173],"88%.":[178],"These":[179],"findings":[180],"show":[181],"share":[188],"fundamental":[189],"characteristics":[190],"across":[191],"diverse":[192],"antigen":[194],"types.":[195],"More":[196],"broadly,":[197],"insights":[198],"into":[199],"antitumor":[200],"gained":[203],"cancers":[206],"likely":[209],"relevant":[212],"mutationally":[214],"driven":[215],"cancers.":[216]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-01-08T00:00:00"}